E-Cigarettes Tied to Quitting Among Smokers Not Trying to Quit
TUESDAY, Jan. 4, 2022 (HealthDay News) — Daily electronic cigarette use is associated with...
Read More
Hematology/Oncology
Tailored Strategies Can Up Depression Referrals in Breast Cancer
TUESDAY, Jan. 4, 2022 (HealthDay News) — For patients with newly diagnosed breast cancer,...
Read More
Physicians Lack Knowledge About Responsibilities Under ADA
TUESDAY, Jan. 4, 2022 (HealthDay News) — More than one-third of U.S. physicians report...
Read More
Blood Cancer in Children
The recovery rate for childhood acute lymphoblastic leukemia is greater than 70% now. The...
Read More
The Relationship Between Non-Relapse Mortality and Economic Factors
There is a strong correlation between a nation’s economic status and the rates of allogeneic...
Read More
Targeting STAT Pathway to Treat Cancer
An active mediator of cytokine signaling in solid and hematologic malignancies is the JAK-STAT...
Read More
Role of sentinel lymph node biopsy for gynecologic cancers.
To provide an overview of the current knowledge and recent advances of sentinel lymph node (SLN)...
Read More
DIAPH1 facilitates paclitaxel-mediated cytotoxicity of ovarian cancer cells.
The chemotherapeutic agent paclitaxel (PTX) selectively binds to and stabilizes microtubule (MTs)....
Read More
Breast Cancer Survival Up With Access to Integrative Therapies
WEDNESDAY, Dec. 29, 2021 (HealthDay News) — Institutional involvement in integrative...
Read More
Primary Care Clinicians Tailor Colorectal Cancer Screening to Patients
WEDNESDAY, Dec. 29, 2021 (HealthDay News) — Clinicians, both primary care clinicians (PCCs)...
Read More
Guidance Offered for Managing Pain in Patients With Cancer and OUD
WEDNESDAY, Dec. 29, 2021 (HealthDay News) — The appropriateness of strategies for managing...
Read More
U.S. Adults Support Net-Risk Pediatric Research
TUESDAY, Dec. 28, 2021 (HealthDay News) — The majority of U.S. adults support net-risk...
Read More
Factors Considered by Cancer Patients in Their Choice to Stop Therapy
Lifelong oral tyrosine kinase inhibitor (TKI) therapy happens to be the conventional treatment for...
Read More
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation.
Epithelial ovarian cancer (EOC) is a highly heterogeneous disease encompassing several distinct...
Read More
Risks factors for anastomotic leakage in advanced ovarian cancer: A systematic review and meta-analysis.
This systematic review and meta-analysis aimed to summarise the available evidence on the pre- and...
Read More
PTEN Hamartoma Tumour Syndrome (PHTS) and the Viability of Risk Assessment Tools
Patients who are diagnosed with the Cowden syndrome or other syndromes with germline alteration of...
Read More
Prostate Cancer Screening Declined Following 2012 USPSTF Guidance
WEDNESDAY, Dec. 22, 2021 (HealthDay News) — There were large temporal changes in screening,...
Read More
Oropharyngeal Cancer Incidence, Mortality Up Among U.S. Men
THURSDAY, Dec. 23, 2021 (HealthDay News) — The incidence of oropharyngeal cancer (OPC)...
Read More
Oropharyngeal Cancer Incidence, Mortality Up Among U.S. Men
THURSDAY, Dec. 23, 2021 (HealthDay News) — The incidence of oropharyngeal cancer (OPC)...
Read More
Pembrolizumab – A Robust Counter to Cancer and Lynch Syndrome That Is Caused By MSH6 Gene Mutation
Advanced tumors lacking in mismatch repair (MMR) were very responsive to pembrolizumab which is a...
Read More